Hongli Peng

1.4k citations
30 papers · 1.1k indexed · h-index 15
Topics
Glycosylation and Glycoproteins Research (4 papers)Nitric Oxide and Endothelin Effects (4 papers)Monoclonal and Polyclonal Antibodies Research (4 papers)
Partner nations
ChinaAustraliaDenmark

In The Last Decade

Hongli Peng

27 papers receiving 1.1k citations

Peers

Hongli Peng
Comparison fields: 5 of 101
  • Molecular Biology 613
  • Physiology 287
  • Pharmacology 183
  • Cardiology and Cardiovascular Medicine 161
  • Endocrinology, Diabetes and Metabolism 144
Replace Xiaofang Fan with:
Xiaofang Fan China
Han‐Wu Deng China
Italia Papparella Italy
Ryo Yoshimoto Japan
Javier Pizarro‐Delgado Spain
Chunhua Zhu China
Guifen Qiang China
Kaipeng Huang China
Pao‐Yun Cheng Taiwan
Yanjun Liu United States
Hongli Peng relative to Xiaofang Fan China Xiaofang Fan's profile →
Citations per field
00.5×1.5×1.8×
Xiaofang Fan · 1×
Citations per year

Countries citing papers authored by Hongli Peng

Since Specialization
Citations

This map shows the geographic impact of Hongli Peng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hongli Peng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hongli Peng more than expected).

Fields of papers citing papers by Hongli Peng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hongli Peng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hongli Peng. The network helps show where Hongli Peng may publish in the future.

Co-authorship network of co-authors of Hongli Peng

This figure shows the co-authorship network connecting the top 25 collaborators of Hongli Peng. A scholar is included among the top collaborators of Hongli Peng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hongli Peng. Hongli Peng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 0
3 0
4 9
5 59
6 12
7 11
8 18
9 45
10 19
11 6
12 140
13 6
14 13
15 84
16 127
17 77
18 38
19 56
20 69

About Hongli Peng

Hongli Peng is a scholar working on Pharmacology, Physiology and Molecular Biology, having authored 30 papers that have together received 1.1k indexed citations. Recurring topics across this work include Glycosylation and Glycoproteins Research (4 papers), Nitric Oxide and Endothelin Effects (4 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). The work is most often cited by research in Physiology (287 citations), Pharmacology (183 citations) and Molecular Biology (613 citations). Hongli Peng has collaborated with scholars based in China, Australia and Denmark. Frequent co-authors include Christian Aalkjær, Holger Nilsson, Vladimir V. Matchkov, Jingkang Shen, Anders Ivarsen, Ying Ma, Zhi‐Yan Du, Xin Wang, Ying Wang and Zhiyan Du. Their work appears in journals such as PLoS ONE, Circulation Research and British Journal of Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026